SCHEMBL2292249

SCHEMBL2292249

CN1CCCc2cc(N=O)ccc21

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.58
MAPT P10636 2/20 0.58
GAA P10253 2/20 0.58
HPGD P15428 2/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
WDR5 P61964 1/20 0.42
KDM4E B2RXH2 2/20 0.39
NPSR1 Q6W5P4 2/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MAPK1 P28482 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
KCNH2 Q12809 1/20 0.38
ACHE P22303 1/20 0.38
POLB P06746 1/20 0.36
HSD17B10 Q99714 2/20 0.36
GLA P06280 1/20 0.36
CASP1 P29466 1/20 0.36
PRKAB2 O43741 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL9015957 0.98 ALDH1A1 (0.56) ALDH1A1MAPTGAAHPGDMEN1
SCHEMBL13622297 0.82 MAPT (0.53) ALDH1A1MAPTGAAHPGDMEN1
SCHEMBL5982043 0.78 MAPT (0.49) ALDH1A1MAPTGAAHPGDMEN1
SCHEMBL5982042 0.78 MAPT (0.49) ALDH1A1MAPTGAAHPGDMEN1
SCHEMBL142527 0.77 MAPT (0.48) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL2292659 0.77 ALDH1A1 (0.41) ALDH1A1MAPTGAAHPGDMEN1
SCHEMBL14573732 0.77 MAPT (0.46) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL434992 0.77 ALDH1A1 (0.62) ALDH1A1MAPTGAAHPGDMEN1
Hydrochloric Acid SCHEMBL9015908 0.76 NOS3 (0.47) ALDH1A1MAPTGAAMEN1KMT2A
SCHEMBL5985317 0.76 KMT2A (0.47) ALDH1A1MAPTGAAHPGDMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5286362-A Reducible substance is enzymatically reduced and oxidized at the electrode; substance formed by oxidation is different from the reducible substance used initially BOEHRINGER MANNHEIM GMBH (DE) 1994-02-15 US claimed
EP-2265726-B1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIAGNOSTICS GMBH (DE) 2014-05-07 EP disclosed
US-8535511-B2 Methods for electrochemical analysis using matrix compositions with alkylphenazine quaternary salt and a nitrosoaniline ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2013-09-17 US disclosed
US-8008037-B2 Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline ROCHE DIAGNOSTICS OPERATIONS, INC. (US) 2011-08-30 US disclosed
EP-2265726-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY Roche Diagnostics GmbH (DE) 2010-12-29 EP disclosed
WO-2009118157-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIAGNOSTICS GMBH (DE) 2009-10-01 WO disclosed
US-20090246808-A1 BIOSENSOR WITH IMPROVED ANALYTE SPECIFICITY ROCHE DIABETES CARE, INC. 2009-10-01 US disclosed
EP-0441222-B1 Process and electrode system for determining an analyte or an oxidoreductase as well as suitable compounds BOEHRINGER MANNHEIM GMBH (DE) 1996-12-18 EP disclosed
US-5286362-A Reducible substance is enzymatically reduced and oxidized at the electrode; substance formed by oxidation is different from the reducible substance used initially BOEHRINGER MANNHEIM GMBH (DE) 1994-02-15 US disclosed
US-5122244-A Having a reducible nitroso or oxime compound to transfer electrons leading to a signal and form an aromatic amine oxidizable to a compound different from the original; low voltage BOEHRINGER MANNHEIM GMBH (DE) 1992-06-16 US disclosed
EP-0441222-A2 Process and electrode system for determining an analyte or an oxidoreductase as well as suitable compounds Roche Diagnostics GmbH (DE) 1991-08-14 EP disclosed